Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib. Haematologica 2019 May;104(5):e218-e221
Date
03/02/2019Pubmed ID
30819904Pubmed Central ID
PMC6518893DOI
10.3324/haematol.2018.215103Scopus ID
2-s2.0-85065466454 (requires institutional sign-in at Scopus site) 15 CitationsAuthor List
Graetz D, Crews KR, Azzato EM, Singh RK, Raimondi S, Mason J, Valentine M, Mullighan CG, Holland A, Inaba H, Leventaki VMESH terms used to index this publication - Major topics in bold
Antineoplastic AgentsHumans
Infant
Lymphoma, Large-Cell, Anaplastic
Male
Oncogene Proteins, Fusion
Poly(A)-Binding Protein I
Prognosis
